James Patrick Nelli Jr. - Jun 15, 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
President
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Jun 15, 2021
Transactions value $
-$193,787
Form type
4
Date filed
6/17/2021, 06:12 PM
Previous filing
Jun 3, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Sale -$166K -2.95K -2.16% $56.40 134K Jun 15, 2021 Direct F1, F2
transaction HCAT Common Stock Sale -$27.4K -480 -0.36% $57.09 133K Jun 15, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 10, 2021 in accordance with Rule 10b5-1.
F2 Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.93 to $56.89, inclusive.
F3 Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $56.96 to $57.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth Footnotes (2) and (3).